Evidence map›Paper›PMID 37734845›Full record

ArticleJournal of medical genetics2024

Diagnostic genome sequencing improves diagnostic yield: a prospective single-centre study in 1000 patients with inherited eye diseases.

Nicole Weisschuh, Pascale Mazzola, Theresia Zuleger, Karin Schaeferhoff, Laura Kühlewein, Friederike Kortüm, Dennis Witt, Alexandra Liebmann, Ruth Falb, Lisa Pohl and 24 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of medical genetics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
18.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Identification of biallelic loss-of-functionJournal of medical genetics · 2026
    Article
  5. Persistent diffuse photoreceptor disorganization: further evidence with potential associations, long-term clinical course and therapeutic responsiveness of a new clinical entity.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Artificial intelligence applications in inherited retinal dystrophies.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors at 3 institutions in 1 country.

Nicole Weisschuh *Institute for Ophthalmic Research, Centre for Ophthalmology, University of Tübingen, Tübingen, Germany.
Pascale Mazzola *Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
Theresia Zuleger *Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
Karin SchaeferhoffInstitute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
Laura KühleweinUniversity Eye Hospital, Centre for Ophthalmology, University of Tübingen, Tübingen, Germany.
Friederike KortümUniversity Eye Hospital, Centre for Ophthalmology, University of Tübingen, Tübingen, Germany.
Dennis WittInstitute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
Alexandra LiebmannInstitute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
Ruth FalbInstitute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
Lisa PohlUniversity Eye Hospital, Centre for Ophthalmology, University of Tübingen, Tübingen, Germany.
Milda ReithUniversity Eye Hospital, Centre for Ophthalmology, University of Tübingen, Tübingen, Germany.
Lara G StühnInstitute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
Miriam BertrandInstitute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
Amelie MüllerInstitute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
Nicolas CasadeiInstitute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.ORCID 0000-0003-2209-0580
Olga KelemenInstitute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
Carina KelbschUniversity Eye Hospital, Centre for Ophthalmology, University of Tübingen, Tübingen, Germany.
Christoph KernstockUniversity Eye Hospital, Centre for Ophthalmology, University of Tübingen, Tübingen, Germany.
Paul RichterUniversity Eye Hospital, Centre for Ophthalmology, University of Tübingen, Tübingen, Germany.
Francoise SadlerUniversity Eye Hospital, Centre for Ophthalmology, University of Tübingen, Tübingen, Germany.
German DemidovInstitute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
Leon SchützInstitute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
Jakob AdmardInstitute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
Marc SturmInstitute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
Ute GrasshoffInstitute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
Felix TonagelUniversity Eye Hospital, Centre for Ophthalmology, University of Tübingen, Tübingen, Germany.
Tilman HeinrichInstitute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
Fadi NasserUniversity Eye Hospital, Centre for Ophthalmology, University of Tübingen, Tübingen, Germany.
Bernd WissingerInstitute for Ophthalmic Research, Centre for Ophthalmology, University of Tübingen, Tübingen, Germany.
Stephan OssowskiInstitute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
Susanne KohlInstitute for Ophthalmic Research, Centre for Ophthalmology, University of Tübingen, Tübingen, Germany.
Olaf RiessInstitute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
Katarina StinglUniversity Eye Hospital, Centre for Ophthalmology, University of Tübingen, Tübingen, Germany tobias.haack@med.uni-tuebingen.de Katarina.Stingl@med.uni-tuebingen.de.
Tobias B HaackInstitute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany tobias.haack@med.uni-tuebingen.de Katarina.Stingl@med.uni-tuebingen.de.ORCID 0000-0001-6033-4836
University of Tübingen · DESTZ eyetrial · DEPraxis für Humangenetik · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeGenome sequencing (GS) is expected to reduce the diagnostic gap in rare disease genetics. We aimed to evaluate a scalable framework for genome-based analyses 'beyond the exome' in regular care of patients with inherited retinal degeneration (IRD) or inherited optic neuropathy (ION).

methodsPCR-free short-read GS was performed on 1000 consecutive probands with IRD/ION in routine diagnostics. Complementary whole-blood RNA-sequencing (RNA-seq) was done in a subset of 74 patients. An open-source bioinformatics analysis pipeline was optimised for structural variant (SV) calling and combined RNA/DNA variation interpretation.

resultsA definite genetic diagnosis was established in 57.4% of cases. For another 16.7%, variants of uncertain significance were identified in known IRD/ION genes, while the underlying genetic cause remained unresolved in 25.9%. SVs or alterations in non-coding genomic regions made up for 12.7% of the observed variants. The RNA-seq studies supported the classification of two unclear variants.

conclusionGS is feasible in clinical practice and reliably identifies causal variants in a substantial proportion of individuals. GS extends the diagnostic yield to rare non-coding variants and enables precise determination of SVs. The added diagnostic value of RNA-seq is limited by low expression levels of the major IRD disease genes in blood.

Indexed as

ExomeEye DiseasesBase SequenceHumansProspective StudiesRNARNAeye diseasesgenomicsmolecular diagnostic techniquesRNA-seq

Identifiers

PMID37734845
PMCPMC10850689
OpenAlexW4386923407

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.